In addition to its role in angiogenesis, several reports have investigated the role of Egr3 in breast cancer, where it was found to be an estrogen-responsive gene whose immunoreactivity is positively associated with estrogen receptor α (ERα) status, lymph node status, and distant metastasis [24], [25]. The gene discussed is ESR1; the disease is breast cancer.